Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.54 |
| ▸ | CES1 | P23141 | 4/20 | 0.53 |
| ▸ | FAAH | O00519 | 3/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2774750 | 0.98 | MAPT (0.58) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL27608422 | 0.93 | HDAC1 (0.58) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL11119017 | 0.89 | MAPT (0.59) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL11418333 | 0.89 | MAPT (0.59) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL28174460 | 0.86 | FFAR1 (0.56) | MAPTRXFP1MGLL | |
| SCHEMBL14952781 | 0.86 | TDP1 (0.63) | MAPTHDAC1HDAC2HDAC3MAPK1 | |
| SCHEMBL27428759 | 0.84 | TDP1 (0.61) | MAPTHDAC1HDAC2HDAC3MAPK1 | |
| SCHEMBL11578613 | 0.82 | MAPT (0.69) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL10623470 | 0.82 | MAPT (0.69) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL7655514 | 0.82 | MAPT (0.69) | MAPTRXFP1ALOX5HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050059605-A1 | Chemically modified metabolites of regulatory peptides and methods of producing and using same | THERATECHNOLOGIES INC. (CA) | 2005-03-17 | — | — | US | disclosed |
| WO-2004067548-A2 | CHEMICALLY MODIFIED METABOLITES OF REGULATORY PEPTIDES AND METHODS OF PRODUCING AND USING SAME | THERATECHNOLOGIES INC. (CA) | 2004-08-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059605-A1 | Chemically modified metabolites of regulatory peptides and methods of producing and using same | PTMS, DPP7, GIPR | MAPT 4836/4885RXFP1 79/4885ALOX5 4176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.